ACAD
ACADIA Pharmaceuticals Inc
19.60$
-0.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +127.1% | +27.8% | +99.4% | +16.7% | +22.4% | +12.2% | +16.8% | +2.2% | +2.2% | +5.7% | +32.2% | +13.7% | +4.0% | -8.4% | +22.2% | +9.5% | +0.4% | -11.9% | +8.1% | +14.2% | -0.6% | -11.7% | +16.5% | -2.9% | +4.4% | -13.2% | +39.5% | +28.1% | +9.1% | -10.9% | +17.6% | +3.5% | +3.7% | -5.9% | +8.3% | +5.3% | +1.9% | -5.6% | +14.9% | – | |
| – | +75.2% | +27.1% | +9.1% | +0.2% | +15.3% | -5.9% | +45.7% | +5.8% | -18.3% | +4.3% | +9.1% | -6.1% | +13.8% | -6.7% | +10.1% | -12.3% | +10.4% | -11.5% | +11.0% | +28.4% | -61.7% | +15.2% | -9.6% | -19.9% | +13.0% | -30.9% | +347.5% | +96.0% | +22.4% | +28.3% | -20.6% | +3.4% | +15.6% | -6.5% | +1.7% | +4.4% | +21.1% | -5.5% | +14.2% | – | |
| – | +144.4% | +28.0% | +120.8% | +18.7% | +23.2% | +13.9% | +14.5% | +1.8% | +4.2% | +5.8% | +34.0% | +14.9% | +3.4% | -8.5% | +23.0% | +10.7% | -0.1% | -12.0% | +8.0% | +13.6% | +2.6% | -12.2% | +17.2% | -2.5% | +4.3% | -12.9% | +35.1% | +24.9% | +8.2% | -14.2% | +22.3% | +3.5% | +2.7% | -5.8% | +8.9% | +5.4% | +0.3% | -5.6% | +15.0% | – | |
| – | +17.1% | +17.2% | -3.5% | +6.6% | +18.6% | -9.0% | +18.6% | +14.0% | -9.3% | +9.8% | +27.2% | -7.0% | -8.1% | +26.3% | -11.5% | +86.8% | -48.3% | -8.3% | -0.1% | +2.9% | +14.3% | +92.5% | -41.3% | +7.5% | -6.9% | -8.7% | -15.0% | +167.1% | -57.5% | -10.6% | +27.7% | -12.6% | +51.2% | -22.3% | -0.4% | +12.7% | -3.5% | -9.3% | +6.1% | – | |
| – | +14.1% | +14.0% | -6.4% | +1.2% | -17.9% | +19.3% | +14.0% | -12.1% | -43.6% | +170.1% | -27.0% | +6.9% | +26.4% | +11.0% | -17.3% | -3.3% | -14.6% | +60.3% | -13.3% | -15.6% | +18.5% | -0.1% | -7.0% | -13.1% | +26.6% | +2.4% | -5.2% | +2.0% | +4.3% | +5.8% | +8.4% | +13.9% | -2.4% | -2.9% | +5.6% | -0.1% | +16.7% | +9.9% | -6.3% | – | |
| – | +15.1% | +15.1% | -5.4% | +3.1% | +11.3% | -8.8% | +15.8% | -1.6% | +7.2% | +19.2% | -7.3% | +0.0% | +10.4% | +16.9% | -14.9% | +35.7% | -9.3% | -7.8% | -8.8% | -8.8% | +23.3% | +30.5% | -26.6% | -3.7% | +13.0% | -5.4% | -9.2% | +64.7% | -30.1% | -5.9% | +15.3% | +3.4% | -57.8% | +142.8% | +3.3% | +4.6% | +8.7% | +3.1% | -2.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,002.4% | – | -56.5% | +100.1% | +4.0% | +385.1% | -87.4% | +67.8% | +10.4% | -51.4% | -126.5% | – | – | |
| – | +11.5% | +9.9% | +3.1% | +7.0% | +4.1% | +5.7% | +9.3% | -3.9% | +35.9% | +75.7% | -13.9% | -3.8% | +34.5% | -8.6% | -38.9% | -31.9% | -55.4% | -63.9% | -33.5% | -3.0% | +0.0% | -18.6% | +452.4% | +295.7% | +58.2% | +149.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -922.1% | – | -47.1% | +77.0% | +4.4% | +315.1% | -82.8% | +44.8% | +10.9% | -41.0% | -84.9% | +1,067.4% | – | |
| – | – | -93.7% | +368.2% | +67.6% | -104.6% | – | -66.2% | +71.7% | -96.3% | +2,578.6% | -2.7% | -172.3% | – | -1,013.3% | – | -150.6% | – | -95.0% | +2,152.4% | -170.2% | – | +156.6% | -8.7% | +73.4% | +8.7% | -329.7% | – | +149.2% | -146.8% | – | -14.7% | +59.3% | +187.1% | -49.3% | +54.1% | -300.7% | – | – | +4,252.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5,950.6% | – | -63.9% | +101.7% | -1.9% | +338.7% | -86.8% | +40.4% | +169.2% | +281.1% | -98.7% | +766.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -721.8% | – | -35.8% | +49.8% | +4.1% | -70.5% | +151.8% | +40.4% | +10.2% | -38.5% | -76.2% | +364.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.